Kawasaki Disease (Post nr. 4210)
[ visa ren ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 06134nam a22004935i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 60560 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20200226102431.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 160827s2017 ja | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9784431560395 |
| -- | 978-4-431-56039-5 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-4-431-56039-5 |
| Source of number or code | doi |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (DE-He213)978-4-431-56039-5 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RJ1-570 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJW |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED069000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 618.92 |
| Edition number | 23 |
| 245 10 - TITLE STATEMENT | |
| Title | Kawasaki Disease |
| Medium | [electronic resource] : |
| Remainder of title | Current Understanding of the Mechanism and Evidence-Based Treatment / |
| Statement of responsibility, etc. | edited by Ben Tsutomu Saji, Jane W. Newburger, Jane C. Burns, Masato Takahashi. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Tokyo : |
| Name of producer, publisher, distributor, manufacturer | Springer Japan : |
| -- | Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2017. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XIX, 552 p. 77 illus., 38 illus. in color. |
| Other physical details | online resource. |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS | |
| File type | text file |
| Encoding format | |
| Source | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Part I: Basic Research -- 1 The History of Kawasaki Disease: A Personal Perspective -- 2 Histopathology of coronary arteritis in acute Kawasaki disease and murine systemic vasculitis induced by Candida albicans cell wall polysaccharide -- 3Histopathological characteristics aspects of organs other than the heart of noncardiac organs in Kawasaki disease -- 4 Identification of Novel Kawasaki Disease Susceptibility Genes by Genome-Wide Association Studies -- 5 Immunological Abnormalities and Use of Biomarkers and Cytokines to Predict the Severity of Kawasaki Disease -- 6 Pathophysiology of Kawasaki Disease -- 7 Update on Pathogenesis: Lessons Learned from Animal Models of Disease -- 8 The climate–KD link -- 9 Kawasaki Disease Shock Syndrome -- 10 Future directions in Kawasaki disease research -- Part II: Epidemiology -- 11 Epidemiologic Perspectives -- 12 Update on nationwide surveys and epidemiologic characteristics of Kawasaki disease in Japan -- 13 Kawasaki Disease Epidemiology in Europe -- 14 Recent topics in the epidemiology of Kawasaki disease -- Part III: Diagnosis and Examinations -- 15 Overview of Medical Treatment -- 16 Overview of the New Japanese Guideline2012 for the Medical Treatment of Acute Stage of Kawasaki Disease -- 17 Tumor Necrosis Factor-α Blockade for Treatment of Acute Kawasaki Disease -- 18 Methylprednisolone Pulse Therapy for Nonresponders to Immunoglobulin Therapy -- 19 Prednisolone -- 20 Cyclosporin A for IVIG nonresponders -- 21 Other challenging therapies -- 22 Antiplatelet and Antithrombotic Therapy for Giant Coronary Aneurysm -- 23 Characteristics of Sudden Cardiac Death Late After Acute Kawasaki Disease -- 24 Kawasaki disease diagnosis and complication rates in the United States and Japan -- 25 Mechanism of Action of Immunoglobulin: Sialylated IgG -- 26 Treatment Options for Refractory Kawasaki Disease: Alternative Treatments for Infliximab Nonresponders -- 27 Ulinastatin -- 28 Diagnosis and Management of Cardiovascular Risk Factors -- 29 Diagnosis and Characteristics of Typical and Incomplete Kawasaki Disease -- 30 Scoring systems to predict coronary artery lesions and nonresponse to initial intravenous immunoglobulin therapy -- 31 Use of magnetic resonance angiography for assessment of coronary artery lesions caused by Kawasaki disease -- 32 CT coronary and myocardial images in patients with coronary artery lesions -- 33 Long-Term Follow-up and Education Regarding Daily Life Activities, School Life, and Guidelines After Acute KD -- 34 Assessment of cardiac ischemia during acute and long-term follow-up and rheologic assessment of coronary artery lesions after Kawasaki disease -- 35 Promising biomarkers in acute Kawasaki disease and acute coronary ischemia -- 36 Coronary artery diameter Z score calculator -- 37 Evidence of endothelial damage in acute KD -- 38 Oxidative Stress in Kawasaki Disease -- Part V: Catheter Intervention and Surgery -- 39 Antiplatelet and anticoagulant therapies for Kawasaki disease: theory and practice -- 40 Guidelines for catheter intervention for coronary artery lesions in Kawasaki disease -- 41 Long-term Clinical Follow-up After Rotational Atherectomy for Coronary Arterial Stenosis in Kawasaki Disease -- 42 Long-term outcomes of pediatric coronary artery bypass grafting and downsizing for giant coronary aneurysms -- 43 Long-term outcomes of pediatric coronary artery bypass grafting and downsizing for giant coronary aneurysms -- Part VI: Follow-up Concerns -- 44 Functional and structural alterations of coronary arteries late after Kawasaki disease and the risk of acute coronary syndrome in adults -- 45 Psychosocial Effects of Kawasaki Disease and Transition to Adult Care -- 46 Kawasaki Disease: Road Map for the Future -- Appendix: Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book provides the most up-to-date information on the clinical research into and medical management of Kawasaki Disease, and opens the door for new pathological insights. Its nearly 50 sections cover basic research, genetic backgrounds, bacterial and biological evidence, and medical treatment with intravenous immunoglobulin, steroids, and recent anti-cytokine approaches. It offers an invaluable resource for general pediatricians, pediatric and adult cardiologists, pediatric cardiac surgeons, infectious disease specialists, pediatric rheumatologists, epidemiologists, and basic researchers in these disciplines. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cardiology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pediatrics. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pediatrics. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cardiology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Saji, Ben Tsutomu. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Newburger, Jane W. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Burns, Jane C. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Takahashi, Masato. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Printed edition: |
| International Standard Book Number | 9784431560371 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://dx.doi.org/10.1007/978-4-431-56039-5">http://dx.doi.org/10.1007/978-4-431-56039-5</a> |
| 912 ## - | |
| -- | ZDB-2-SME |
Inga exemplar finns tillgängliga.